Loading…
Protecting Access to Medicare Act of 2014
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
44pct
6d open
vs 5,821 other HR bills in the 113th — cohort avg 49d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
Yes
128
No
70
Present
0
Not Voting
2
Party Breakdown
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (240)
Bills with similar content found using semantic analysis.
Sources: Congress.gov · House Clerk roll-call votes
| #92 | senate | On the Motion | Motion Agreed to (64-35, 3/5 majority required) | March 31, 2014 |
| #93 | senate | On Passage of the Bill | Bill Passed (64-35, 3/5 majority required) | March 31, 2014 |
2020 · first_quarter · Medicare/Medicaid
Protecting Access to Medicare Beneficiaries Act of 2014, HR 4302 P.L. 113-93 Reimbursement for clinical laboratories Clinical Laboratory Fee Schedule (CLFS) Eliminating Kickbacks in Recovery Act (EKRA) of 2018 LAB Act (HR 3584) Surprise Billing
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Medicare treatment of outpatient reimbursement for laboratory tests.
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payment for clinical laboratory tests.
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Medicare/Medicaid
PL 113-93 (H.R. 4302) - Protecting Access to Medicare Act of 2014; Implementation of changes to Medicare payment for clinical laboratory tests.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
Issues related to CMS Calendar Year 2019 Physician Fee Schedule proposed rule, proposed reduction to general ultrasound and vascular ultrasound room equipment codes; H.R. 4302, Protecting Access to Medicare Act of 2014, Sec. 220.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Medicare/Medicaid
Protecting Access to Medicare Beneficiaries Act of 2014, HR 4302 P.L. 113-93 Reimbursement for clinical laboratories Clinical Laboratory Fee Schedule (CLFS) Eliminating Kickbacks in Recovery Act (EKRA) of 2018 LAB Act (HR 3584) Surprise Billing
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payment for clinical laboratory tests.
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Health Issues
Issues related to CMS Calendar Year 2019 Physician Fee Schedule proposed rule, proposed reduction to general ultrasound and vascular ultrasound room equipment codes; H.R. 4302, Protecting Access to Medicare Act of 2014, Sec. 220.
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Health Issues
Issues related to CMS Calendar Year 2019 Physician Fee Schedule proposed rule, proposed reduction to general ultrasound and vascular ultrasound room equipment codes; H.R. 4302, Protecting Access to Medicare Act of 2014, Sec. 220.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Medicare/Medicaid
PL 113-93 (H.R. 4302) - Protecting Access to Medicare Act of 2014; Implementation of changes to Medicare payment for clinical laboratory tests.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Medicare/Medicaid
Protecting Access to Medicare Beneficiaries Act of 2014, HR 4302 P.L. 113-93 Reimbursement for clinical laboratories Clinical Laboratory Fee Schedule (CLFS) Eliminating Kickbacks in Recovery Act (EKRA) of 2018 LAB Act (HR 3584) Surprise Billing
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Health Issues
Issues related to CMS Calendar Year 2019 Physician Fee Schedule proposed rule, proposed reduction to general ultrasound and vascular ultrasound room equipment codes; H.R. 4302, Protecting Access to Medicare Act of 2014, Sec. 220.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payment for clinical laboratory tests.
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Medicare/Medicaid
PL 113-93 (H.R. 4302) - Protecting Access to Medicare Act of 2014; Implementation of changes to Medicare payment for clinical laboratory tests.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Medicare/Medicaid
Protecting Access to Medicare Beneficiaries Act of 2014, HR 4302 P.L. 113-93 Reimbursement for clinical laboratories Clinical Laboratory Fee Schedule (CLFS) Eliminating Kickbacks in Recovery Act (EKRA) of 2018 LAB Act (HR 3584) Surprise Billing
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · first_quarter · Health Issues
Issues related to CMS Calendar Year 2019 Physician Fee Schedule proposed rule, proposed reduction to general ultrasound and vascular ultrasound room equipment codes; H.R. 4302, Protecting Access to Medicare Act of 2014, Sec. 220.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · first_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · first_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payment for clinical laboratory tests.
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · first_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · first_quarter · Medicare/Medicaid
PL 113-93 (H.R. 4302) - Protecting Access to Medicare Act of 2014; Implementation of changes to Medicare payment for clinical laboratory tests.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · first_quarter · Medicare/Medicaid
Protecting Access to Medicare Beneficiaries Act of 2014, HR 4302 P.L. 113-93 Reimbursement for clinical laboratories Clinical Laboratory Fee Schedule (CLFS) Eliminating Kickbacks in Recovery Act (EKRA) of 2018
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
Issues related to CMS Calendar Year 2019 Physician Fee Schedule proposed rule, proposed reduction to general ultrasound and vascular ultrasound room equipment codes; H.R. 4302, Protecting Access to Medicare Act of 2014, Sec. 220.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payment for clinical laboratory tests. H.R.6: SUPPORT for Patients and Communities Act, as it relates to all-payor anti-kickback provisions.
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
Issues related to CMS Calendar Year 2019 Physician Fee Schedule proposed rule, proposed reduction to general ultrasound and vascular ultrasound room equipment codes; H.R. 4302, Protecting Access to Medicare Act of 2014, Sec. 220.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Medicare/Medicaid
PL 113-93 (HR 4302) - Protecting Access to Medicare Act of 2014; implementation of changes to Medicare payment for clinical laboratory tests.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Medicare/Medicaid
H.R. 4302 - Protecting Access to Medicare Act of 2014. Medicare physician fee schedule for patient self-testing prothrombin time; Competitive bidding program for diabetes testing supplies.
Client expense: $120,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · fourth_quarter · Medicare/Medicaid
H.R.4302, Protecting Access to Medicare Act (PAMA) - implementation and Medicare reimbursement for clinical laboratory tests.
Client expense: $1,020,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2018 · fourth_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payment for clinical laboratory tests. FDA regulation of laboratory developed tests. Medicare treatment of outpatient reimbursement for laboratory tests.
Client expense: Not reported · Firm income: $10,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Medicare/Medicaid
PL 113-93 (HR 4302) - Protecting Access to Medicare Act of 2014; implementation of changes to Medicare payment for clinical laboratory tests.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Medicare/Medicaid
Protecting Access to Medicare Beneficiaries Act of 2014, H.R. 4302 P.L. 113-93 Reimbursement for clinical laboratories Clinical Laboratory Fee Schedule (CLFS)
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payment for clinical laboratory tests. FDA regulation of laboratory developed tests. Medicare treatment of outpatient reimbursement for laboratory tests.
Client expense: Not reported · Firm income: $10,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payment for clinical laboratory tests. FDA regulation of laboratory developed tests. Medicare treatment of outpatient reimbursement for laboratory tests.
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Medical/Disease Research/Clinical Labs
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payment for clinical laboratory tests. FDA regulation of laboratory developed tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA draft guidance to regulate laboratory developed tests and companion diagnostics. Legislation to further regulate clinical labs under CLIA and/or FDA (legislation not yet introduced).
Client expense: Not reported · Firm income: Not reported
2018 · third_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payment for clinical laboratory tests. FDA regulation of laboratory developed tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA draft guidance to regulate laboratory developed tests and companion diagnostics. Legislation to further regulate clinical labs under CLIA and/or FDA (legislation not yet introduced).
Client expense: Not reported · Firm income: Not reported
2018 · third_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payment for clinical laboratory tests. FDA regulation of laboratory developed tests. Medicare treatment of outpatient reimbursement for laboratory tests.
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Medical/Disease Research/Clinical Labs
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payment for clinical laboratory tests. FDA regulation of laboratory developed tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA draft guidance to regulate laboratory developed tests and companion diagnostics. Legislation to further regulate clinical labs under CLIA and/or FDA (legislation not yet introduced).
Client expense: Not reported · Firm income: Not reported
2018 · third_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payment for clinical laboratory tests. FDA regulation of laboratory developed tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA draft guidance to regulate laboratory developed tests and companion diagnostics. Legislation to further regulate clinical labs under CLIA and/or FDA (legislation not yet introduced).
Client expense: Not reported · Firm income: Not reported
2018 · third_quarter · Medicare/Medicaid
H.R.4302, Protecting Access to Medicare Act (PAMA) - implementation and Medicare reimbursement for clinical laboratory tests.
Client expense: $910,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Natl Economic Council (NEC), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2018 · third_quarter · Medicare/Medicaid
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payment for clinical laboratory tests. FDA regulation of laboratory developed tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA draft guidance to regulate laboratory developed tests and companion diagnostics. Legislation to further regulate clinical labs under CLIA and/or FDA (legislation not yet introduced).
Client expense: Not reported · Firm income: Not reported
2018 · third_quarter · Medical/Disease Research/Clinical Labs
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payment for clinical laboratory tests. FDA regulation of laboratory developed tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA draft guidance to regulate laboratory developed tests and companion diagnostics. Legislation to further regulate clinical labs under CLIA and/or FDA (legislation not yet introduced).
Client expense: Not reported · Firm income: Not reported
2018 · third_quarter · Health Issues
Issues related to CMS Calendar Year 2019 Physician Fee Schedule proposed rule, proposed reduction to general ultrasound and vascular ultrasound room equipment codes; H.R. 4302, Protecting Access to Medicare Act of 2014, Sec. 220.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Medicare/Medicaid
PL 113-93 (HR 4302) - Protecting Access to Medicare Act of 2014; implementation of changes to Medicare payment for clinical laboratory tests.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE